Founded by scientists from the pharmaceutical, biotech and CRO industries, ANS Biotech is a world-renowned resource providing in vivo services for the development and evaluation of new analgesic treatments.
Exclusively focused in pain, we have delivered efficacy and safety profiles of hundreds of drug candidates for our clients, while constantly developing new models and methods for their future use.
ALGOGram™ 2.0 offers a dual focus on efficacy and safety; an invaluable advantage for researchers looking to understand both the therapeutic effects and potential adverse impacts of compounds in early-stage drug development.
Combined together, ALGOGram™ 2.0 serves as a powerful “GO/NO GO” decision tool. This global fingerprint offers clear, actionable insights, minimizing the risk of progressing with ineffective compounds.
